• SeaStar Medical set agreements for immediate cash exercise of 854,002 outstanding warrants at USD 3.866 per share.
• Transaction targets about USD 3.3 million gross proceeds; warrants had prior exercise prices of USD 6.38 to USD 7.62.
• Company to issue 1,708,004 new unregistered warrants at USD 3.616, split between five-year and 18-month terms.
• Plans to file a resale registration statement within 30 days covering shares issuable on exercise of the new warrants.
• Closing expected on or about Oct. 5, 2026; proceeds earmarked for general corporate purposes, including working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seastar Medical Holding Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032035), on October 05, 2026, and is solely responsible for the information contained therein.